|
|
|
Insider
Information: |
Capello Jeffrey D |
Relationship: |
EVP & Chief Financial ... |
City: |
Wellesley |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
106,104 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$11,048,866 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
106,104 |
|
|
Total
Value |
$11,048,866 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Perkinelmer Inc |
PKI |
SVP & CFO |
2008-01-29 |
91,428 |
2004-01-27 |
0 |
Premium* |
|
Boston Scientific Corp |
BSX |
EVP & Chief Financial ... |
2013-11-27 |
447 |
2009-06-16 |
0 |
Premium* |
|
Tempest Therapeutics, Inc |
TPST |
Director |
2013-03-18 |
11,111 |
2013-03-18 |
0 |
Premium* |
|
Biogen Idec Inc |
BIIB |
EVP & Chief Financial ... |
2020-02-12 |
3,118 |
2019-01-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
68 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BIIB |
Biogen Idec Inc |
EVP & Chief Financial Officer |
|
2020-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,302 |
2,219 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
EVP & Chief Financial Officer |
|
2020-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,919 |
3,732 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2012-02-23 |
4 |
D |
$5.90 |
$15,086 |
D/D |
(2,557) |
119,594 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2012-02-16 |
4 |
D |
$5.97 |
$40,118 |
D/D |
(6,720) |
114,087 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2010-06-16 |
4 |
D |
$6.10 |
$157,984 |
D/D |
(25,899) |
69,297 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2012-02-24 |
4 |
D |
$6.25 |
$5,969 |
D/D |
(955) |
121,651 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2013-11-26 |
4 |
OE |
$6.28 |
$296,129 |
D/D |
46,701 |
194,148 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2012-05-12 |
4 |
D |
$6.31 |
$14,475 |
D/D |
(2,294) |
133,747 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2012-02-28 |
4 |
D |
$6.36 |
$21,122 |
D/D |
(3,321) |
128,805 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2011-06-16 |
4 |
D |
$6.83 |
$31,800 |
D/D |
(4,656) |
100,565 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2013-11-25 |
4 |
OE |
$6.91 |
$1,780,911 |
D/D |
242,504 |
389,951 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2011-02-24 |
4 |
D |
$7.02 |
$6,718 |
D/D |
(957) |
90,559 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2011-02-23 |
4 |
D |
$7.04 |
$18,029 |
D/D |
(2,561) |
88,504 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2011-02-16 |
4 |
D |
$7.10 |
$46,441 |
D/D |
(6,541) |
83,000 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2013-02-27 |
4 |
D |
$7.33 |
$43,760 |
D/D |
(5,970) |
177,154 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2013-02-23 |
4 |
D |
$7.37 |
$19,383 |
D/D |
(2,630) |
162,782 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2013-02-24 |
4 |
D |
$7.37 |
$7,237 |
D/D |
(982) |
164,812 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2013-02-28 |
4 |
D |
$7.39 |
$25,237 |
D/D |
(3,415) |
184,213 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2013-08-29 |
4 |
OE |
$7.41 |
$3,519,750 |
D/D |
475,000 |
535,909 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2013-11-22 |
4 |
OE |
$7.41 |
$1,217,468 |
D/D |
150,000 |
297,447 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2013-02-16 |
4 |
D |
$7.54 |
$50,201 |
D/D |
(6,658) |
157,347 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP, Chief Accounting Officer |
|
2010-02-24 |
4 |
D |
$7.80 |
$8,923 |
D/D |
(1,144) |
21,882 |
0 |
- |
|
PKI |
Perkinelmer Inc |
Chief Accounting Officer |
|
2004-03-03 |
4 |
OE |
$8.16 |
$102,000 |
D/D |
12,500 |
32,500 |
|
- |
|
PKI |
Perkinelmer Inc |
SVP & CFO |
|
2007-05-31 |
4 |
OE |
$8.16 |
$306,000 |
D/D |
37,500 |
110,639 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP & Chief Financial Officer |
|
2013-05-12 |
4 |
D |
$8.45 |
$19,934 |
D/D |
(2,359) |
189,089 |
0 |
- |
|
68 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|